Lexicon Prescribed drugs inventory hits 52-week low at $0.73 By Investing.com
In a difficult yr for Lexicon Prescribed drugs (NASDAQ:) Inc., the corporate's…
Analyst sees 30% upside for Lexicon as new trial knowledge boosts sotagliflozin’s prospects By Investing.com
On Wednesday, H.C. Wainwright maintained a optimistic outlook on Lexicon Prescription drugs…
